文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Inflammatory indicators such as systemic immune inflammation index (SIII), systemic inflammatory response index (SIRI), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic factors of curative hepatic resections for hepatocellular carcinoma.

作者信息

Gavriilidis Paschalis, Pawlik Timothy M

机构信息

Department of Surgery, Colchester General Hospital, Colchester, UK.

Department of Surgery, The Ohio State University Wexner Medical Center, James Comprehensive Cancer Center, Columbus, OH, USA.

出版信息

Hepatobiliary Surg Nutr. 2024 Jun 1;13(3):509-511. doi: 10.21037/hbsn-23-631. Epub 2024 May 20.

DOI:10.21037/hbsn-23-631
PMID:38911214
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11190525/
Abstract
摘要

相似文献

[1]
Inflammatory indicators such as systemic immune inflammation index (SIII), systemic inflammatory response index (SIRI), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic factors of curative hepatic resections for hepatocellular carcinoma.

Hepatobiliary Surg Nutr. 2024-6-1

[2]
The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke.

J Inflamm Res. 2023-8-23

[3]
The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage.

Front Immunol. 2023

[4]
Relationships Among Serological Indicators and In Vitro High-Throughput Drug Sensitivity Screening Results in Patients with Hepatocellular Carcinoma.

Comb Chem High Throughput Screen. 2024-6-26

[5]
Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma.

Cancer Control. 2023

[6]
Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.

Oncotarget. 2016-11-1

[7]
Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells.

Front Oncol. 2022-4-8

[8]
Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma.

Front Oncol. 2023-7-13

[9]
The Prognostic Capacity of Systemic Inflammation Response Index, Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients with Hypopharyngeal Squamous Cell Carcinoma.

ORL J Otorhinolaryngol Relat Spec. 2022

[10]
Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era.

Cancer Manag Res. 2021-8-31

引用本文的文献

[1]
Association between complete blood count-derived inflammatory biomarkers and renal failure: a cross-sectional study from NHANES 2007-2020.

BMJ Open. 2025-9-1

[2]
mRNA decapping enzyme2 DCP2 expression correlates with progression and prognosis of hepatocellular carcinoma.

Sci Rep. 2025-8-21

[3]
Construction of a predictive model for concurrent infection in liver failure patients based on prognostic nutritional index and inflammatory cytokine analysis.

BMC Gastroenterol. 2025-8-19

[4]
Predicting recurrence and recurrence-free survival in initially unresectable hepatocellular carcinoma: a novel nomogram for patients undergoing conversion hepatectomy with lenvatinib, PD-1 inhibitor, and interventional therapy.

Front Immunol. 2025-7-30

[5]
Study of the interaction between cardiometabolic index and inflammatory index on the risk of prostate cancer development.

Front Immunol. 2025-7-17

[6]
Association of platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and monocyte-lymphocyte ratio with coronary heart disease prevalence in asthma patients: a cross-sectional analysis of NHANES 1999-2018.

J Thorac Dis. 2025-6-30

[7]
Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic Cholangiocarcinoma.

Ann Surg Oncol. 2025-7-9

[8]
Differential impact of neutrophil-to-lymphocyte ratio and time-weighted NLR on mortality and survival in critically ill children: insights from a retrospective study.

Front Pediatr. 2025-5-20

[9]
Association between systemic immune-inflammation index and mortality in critically ill patients with chronic obstructive pulmonary disease: insights from the MIMIC-IV database.

Front Med (Lausanne). 2025-5-16

[10]
Pan-immune-inflammation value and its association with all-cause and cause-specific mortality in the general population: a nationwide cohort study.

Front Endocrinol (Lausanne). 2025-4-30

本文引用的文献

[1]
Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.

Br J Surg. 2023-10-10

[2]
Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma.

Front Oncol. 2023-7-13

[3]
Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.

World J Gastroenterol. 2023-7-14

[4]
Chronic Inflammation's Transformation to Cancer: A Nanotherapeutic Paradigm.

Molecules. 2023-5-29

[5]
Associating liver partition and portal vein ligation or combined transarterial chemo-embolisation and portal vein embolisation for staged hepatectomy for HBV-related hepatocellular carcinoma.

Hepatobiliary Surg Nutr. 2023-4-10

[6]
TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.

Ann Surg Oncol. 2023-6

[7]
Simultaneous portal and hepatic vein embolization is better than portal embolization or ALPPS for hypertrophy of future liver remnant before major hepatectomy: A systematic review and network meta-analysis.

Hepatobiliary Pancreat Dis Int. 2023-6

[8]
Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis.

Hepatobiliary Pancreat Dis Int. 2021-8

[9]
Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery.

Front Oncol. 2020-10-14

[10]
Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis.

J Gastrointest Surg. 2021-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索